Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol"

Saved in:
Bibliographic Details
Published inThe journal of allergy and clinical immunology in practice (Cambridge, MA) Vol. 8; no. 7; p. 2450
Main Authors Shaker, Marcus S, Oppenheimer, John, Grayson, Mitchell, Stukus, David, Hartog, Nicholas, Hsieh, Elena W Y, Rider, Nicholas, Dutmer, Cullen M, Vander Leek, Timothy K, Kim, Harold, Chan, Edmond S, Mack, Doug, Ellis, Anne K, Lang, David, Lieberman, Jay, Fleischer, David, Golden, David B K, Wallace, Dana, Portnoy, Jay, Mosnaim, Giselle, Greenhawt, Matthew
Format Journal Article
LanguageEnglish
Published United States 01.07.2020
Subjects
Albuterol
COVID-19
Humans
Hypersensitivity
Pandemics
SARS-CoV-2
Terbutaline
Online AccessGet more information

Cover

More Information
ISSN:2213-2201
DOI:10.1016/j.jaip.2020.04.016